255 related articles for article (PubMed ID: 22453142)
1. Inhibition of TGFβ signaling and its implications in anticancer treatments.
Calone I; Souchelnytskyi S
Exp Oncol; 2012; 34(1):9-16. PubMed ID: 22453142
[TBL] [Abstract][Full Text] [Related]
2. Targeting TGFbeta-mediated processes in cancer.
Romano MF
Curr Opin Drug Discov Devel; 2009 Mar; 12(2):253-63. PubMed ID: 19333871
[TBL] [Abstract][Full Text] [Related]
3. Large- and small-molecule inhibitors of transforming growth factor-beta signaling.
Akhurst RJ
Curr Opin Investig Drugs; 2006 Jun; 7(6):513-21. PubMed ID: 16784021
[TBL] [Abstract][Full Text] [Related]
4. Selective inhibition of activin receptor-like kinase 5 signaling blocks profibrotic transforming growth factor beta responses in skin fibroblasts.
Mori Y; Ishida W; Bhattacharyya S; Li Y; Platanias LC; Varga J
Arthritis Rheum; 2004 Dec; 50(12):4008-21. PubMed ID: 15593186
[TBL] [Abstract][Full Text] [Related]
5. Rapamycin induces the TGFbeta1/Smad signaling cascade in renal mesangial cells upstream of mTOR.
Osman B; Doller A; Akool el-S; Holdener M; Hintermann E; Pfeilschifter J; Eberhardt W
Cell Signal; 2009 Dec; 21(12):1806-17. PubMed ID: 19666112
[TBL] [Abstract][Full Text] [Related]
6. Non-Smad signaling pathways.
Mu Y; Gudey SK; Landström M
Cell Tissue Res; 2012 Jan; 347(1):11-20. PubMed ID: 21701805
[TBL] [Abstract][Full Text] [Related]
7. Role of TGFbeta signaling in skin carcinogenesis.
Wang XJ
Microsc Res Tech; 2001 Feb; 52(4):420-9. PubMed ID: 11170301
[TBL] [Abstract][Full Text] [Related]
8. Targeting the TGFβ pathway for cancer therapy.
Neuzillet C; Tijeras-Raballand A; Cohen R; Cros J; Faivre S; Raymond E; de Gramont A
Pharmacol Ther; 2015 Mar; 147():22-31. PubMed ID: 25444759
[TBL] [Abstract][Full Text] [Related]
9. Regulating the stability of TGFbeta receptors and Smads.
Lönn P; Morén A; Raja E; Dahl M; Moustakas A
Cell Res; 2009 Jan; 19(1):21-35. PubMed ID: 19030025
[TBL] [Abstract][Full Text] [Related]
10. Escaping from the TGFbeta anti-proliferative control.
Seoane J
Carcinogenesis; 2006 Nov; 27(11):2148-56. PubMed ID: 16698802
[TBL] [Abstract][Full Text] [Related]
11. Exploring anti-TGF-β therapies in cancer and fibrosis.
Hawinkels LJ; Ten Dijke P
Growth Factors; 2011 Aug; 29(4):140-52. PubMed ID: 21718111
[TBL] [Abstract][Full Text] [Related]
12. Autocrine TGFbeta signaling mediates vitamin D3 analog-induced growth inhibition in breast cells.
Yang L; Yang J; Venkateswarlu S; Ko T; Brattain MG
J Cell Physiol; 2001 Sep; 188(3):383-93. PubMed ID: 11473365
[TBL] [Abstract][Full Text] [Related]
13. Transforming the TGFbeta pathway: convergence of distinct lead generation strategies on a novel kinase pharmacophore for TbetaRI (ALK5).
Singh J; Ling LE; Sawyer JS; Lee WC; Zhang F; Yingling JM
Curr Opin Drug Discov Devel; 2004 Jul; 7(4):437-45. PubMed ID: 15338953
[TBL] [Abstract][Full Text] [Related]
14. Inhibition of TGFbeta signaling in cancer therapy.
Arteaga CL
Curr Opin Genet Dev; 2006 Feb; 16(1):30-7. PubMed ID: 16377175
[TBL] [Abstract][Full Text] [Related]
15. LMO4 can interact with Smad proteins and modulate transforming growth factor-beta signaling in epithelial cells.
Lu Z; Lam KS; Wang N; Xu X; Cortes M; Andersen B
Oncogene; 2006 May; 25(20):2920-30. PubMed ID: 16331278
[TBL] [Abstract][Full Text] [Related]
16. Pro-metastasis function of TGFbeta mediated by the Smad pathway.
Kang Y
J Cell Biochem; 2006 Aug; 98(6):1380-90. PubMed ID: 16598746
[TBL] [Abstract][Full Text] [Related]
17. Inhibition of transforming growth factor beta signaling reduces pancreatic adenocarcinoma growth and invasiveness.
Gaspar NJ; Li L; Kapoun AM; Medicherla S; Reddy M; Li G; O'Young G; Quon D; Henson M; Damm DL; Muiru GT; Murphy A; Higgins LS; Chakravarty S; Wong DH
Mol Pharmacol; 2007 Jul; 72(1):152-61. PubMed ID: 17400764
[TBL] [Abstract][Full Text] [Related]
18. Interactome of transforming growth factor-beta type I receptor (TbetaRI): inhibition of TGFbeta signaling by Epac1.
Conrotto P; Yakymovych I; Yakymovych M; Souchelnytskyi S
J Proteome Res; 2007 Jan; 6(1):287-97. PubMed ID: 17203972
[TBL] [Abstract][Full Text] [Related]
19. Dual role of transforming growth factor beta in mammary tumorigenesis and metastatic progression.
Muraoka-Cook RS; Dumont N; Arteaga CL
Clin Cancer Res; 2005 Jan; 11(2 Pt 2):937s-43s. PubMed ID: 15701890
[TBL] [Abstract][Full Text] [Related]
20. Genomic profiling identifies alterations in TGFbeta signaling through loss of TGFbeta receptor expression in human renal cell carcinogenesis and progression.
Copland JA; Luxon BA; Ajani L; Maity T; Campagnaro E; Guo H; LeGrand SN; Tamboli P; Wood CG
Oncogene; 2003 Sep; 22(39):8053-62. PubMed ID: 12970754
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
